“Research on Asian Psychotropic Prescription Pattern (REAP)” has carried out international collaborative research to grasp the actual prescription pattern of psychotropic drugs for patients with schizophrenia and depression in Asian countries. This additional survey aims to review opinions of psychiatrists in Asia and other areas regarding the prescription pattern for patients with schizophrenia and other psychiatric disorders, and also to grasp additional psychiatric practices in each country.
First, we present four clinical case vignettes. After you read each vignette, please answer all questions. If you are unsure about how to answer, please give the answer that best reflects your opinion. This survey should take appropriately 30 minutes to complete.
This study has been approved by the ethical review board of Kyushu University. Collected data including your answers will be announced through academic conferences and published in journals. If you have any questions, please contact us at “firstname.lastname@example.org”.
Naotaka Shinfuku, M.D., Ph.D. (Emeritus Professor, Kobe University School of Medicine, Japan, and Research on East Asian Psychotropic Prescription Pattern Study (REAP)) Norman Sartorius, MD, PhD, FRCpsych (President, Association for the Improvement of Mental Health Programmes, Switzerland) Shigenobu Kanba, M.D., Ph.D. (Professor, Kyushu University, Japan) & Takahiro Kato, M.D., Ph.D. (Associate Professor, Kyushu University, Japan (E-mail: email@example.com)) [Contact address is shown in the last page]